Cargando…
KRAS(G12) mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway
It remains unclear how the signals of mutant KRAS(G12) in the transformed cells spread to the surrounding non-mutated cells and changes the microenvironment to promote tumor formation. We identified that Williams–Beuren syndrome transcription factor (WSTF), a non-secretory protein, was released in c...
Autores principales: | Liu, Yan, Wang, Shu-Qing, Long, Yue-Hong, Chen, Su, Li, Yu-Feng, Zhang, Jing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288175/ https://www.ncbi.nlm.nih.gov/pubmed/27449290 http://dx.doi.org/10.18632/oncotarget.10625 |
Ejemplares similares
-
Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Gao, Qianqian, et al.
Publicado: (2020) -
Targeted Degradation of Oncogenic KRAS(G12C) by VHL-Recruiting
PROTACs
por: Bond, Michael J., et al.
Publicado: (2020) -
Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition
por: Huynh, Minh V., et al.
Publicado: (2022) -
Searching for treatments for non-G12C-KRAS mutant cancers
por: Guo, Christina, et al.
Publicado: (2021) -
TEAD Inhibitors Sensitize KRAS(G12C) Inhibitors via Dual Cell Cycle Arrest in KRAS(G12C)-Mutant NSCLC
por: Tammaccaro, Salvina Laura, et al.
Publicado: (2023)